down arrow

Emcure Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE168P01015
  • NSEID: EMCURE
  • BSEID: 544210
INR
1,391.40
-12.85 (-0.92%)
BSENSE

Dec 05

BSE+NSE Vol: 4.57 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
1,815.14
1,771.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,269.82
2,100.54
2,116.25
1,962.63
2,001.98
1,815.14
1,771.36
Raw Material Cost
420.46
432.50
403.87
399.83
391.49
331.72
372.78
Purchase of Finished goods
625.17
550.48
571.86
428.93
502.30
380.15
369.39
(Increase) / Decrease In Stocks
-156.10
-180.97
-83.62
-46.03
-105.12
-28.76
-71.19
Employee Cost
384.62
393.47
373.37
366.93
355.59
350.40
338.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
520.20
488.28
448.36
451.22
476.85
445.32
450.51
Total Expenditure (Excl Depreciation)
1,794.35
1,683.76
1,713.84
1,600.88
1,621.11
1,478.82
1,460.01
Operating Profit (PBDIT) excl Other Income
475.47
416.78
402.41
361.75
380.87
336.32
311.35
Other Income
3.12
3.70
4.45
-3.24
35.65
23.44
11.74
Operating Profit (PBDIT)
478.59
420.48
406.86
358.51
416.52
359.76
323.09
Interest
32.54
26.76
39.03
31.78
46.22
58.76
65.49
Exceptional Items
0.00
-3.50
-10.38
0.00
0.00
0.00
-0.14
Gross Profit (PBDT)
446.05
390.22
357.45
326.73
370.30
301.00
257.46
Depreciation
104.64
99.46
96.84
96.81
96.90
93.59
90.56
Profit Before Tax
341.42
290.76
260.61
229.92
273.41
207.41
166.90
Tax
90.05
75.97
63.38
73.83
71.86
54.82
45.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
251.37
214.79
197.24
156.09
201.55
152.59
121.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
251.37
214.79
197.24
156.09
201.55
152.59
121.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.91
7.84
8.28
2.37
6.98
8.51
5.85
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
243.46
206.95
188.96
153.72
194.57
144.08
115.17
Equity Capital
189.57
189.51
189.48
189.43
189.10
181.15
181.15
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.84
10.92
9.97
8.11
10.29
7.95
6.36
Diluted Earnings per share
12.85
10.92
9.97
8.12
10.23
7.95
6.36
Operating Profit Margin (Excl OI)
20.95%
19.84%
19.02%
18.43%
19.02%
18.53%
17.58%
Gross Profit Margin
19.65%
18.58%
16.89%
16.65%
18.5%
16.58%
14.53%
PAT Margin
11.07%
10.23%
9.32%
7.95%
10.07%
8.41%
6.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 8.06% vs -0.74% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 17.64% vs 9.52% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 14.08% vs 3.57% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 21.60% vs -31.44% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Emcure Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,269.82
1,084.90
1,184.92
109.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,269.82
1,084.90
1,184.92
109.22%
Raw Material Cost
420.46
225.34
195.12
86.59%
Purchase of Finished goods
625.17
121.34
503.83
415.22%
(Increase) / Decrease In Stocks
-156.10
-1.19
-154.91
-13,017.65%
Employee Cost
384.62
188.26
196.36
104.30%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
520.20
241.55
278.65
115.36%
Total Expenditure (Excl Depreciation)
1,794.35
775.30
1,019.05
131.44%
Operating Profit (PBDIT) excl Other Income
475.47
309.60
165.87
53.58%
Other Income
3.12
15.34
-12.22
-79.66%
Operating Profit (PBDIT)
478.59
324.94
153.65
47.29%
Interest
32.54
1.35
31.19
2,310.37%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
446.05
323.59
122.46
37.84%
Depreciation
104.64
44.44
60.20
135.46%
Profit Before Tax
341.42
279.15
62.27
22.31%
Tax
90.05
71.33
18.72
26.24%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
251.37
207.82
43.55
20.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
251.37
207.82
43.55
20.96%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
7.91
0.00
7.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
243.46
207.82
35.64
17.15%
Equity Capital
189.57
15.66
173.91
1,110.54%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.84
13.27
-0.43
-3.24%
Diluted Earnings per share
12.85
13.08
-0.23
-1.76%
Operating Profit Margin (Excl OI)
20.95%
28.54%
0.00
-7.59%
Gross Profit Margin
19.65%
29.83%
0.00
-10.18%
PAT Margin
11.07%
19.16%
0.00
-8.09%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,269.82 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.06% vs -0.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 13.38% vs 20.38% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 243.46 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 17.64% vs 9.52% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 25.13% vs 39.83% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 475.47 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 14.08% vs 3.57% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 24.84% vs 15.75% in Sep 2024

Quarterly - Interest
Interest 32.54 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.60% vs -31.44% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -29.60% vs -21.58% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.95%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."